Refine
Has Fulltext
- yes (81)
Is part of the Bibliography
- yes (81)
Year of publication
- 2018 (81) (remove)
Document Type
- Doctoral Thesis (80)
- Journal article (1)
Keywords
- Maus (6)
- Thrombozyt (5)
- Staphylococcus aureus (4)
- Stress (4)
- Biene (3)
- Biofilm (3)
- G-Protein gekoppelte Rezeptoren (3)
- Microscopy (3)
- Myc (3)
- Thrombose (3)
- Angst (2)
- Arteriosklerose (2)
- Aspergillus fumigatus (2)
- Cadherine (2)
- Cancer immunotherapy (2)
- Candida albicans (2)
- Entwicklung (2)
- Epigenetik (2)
- Hippocampus (2)
- Hämostase (2)
- Metabolismus (2)
- Mikroskopie (2)
- Neurogenese (2)
- Phänologie (2)
- Schlaganfall (2)
- Signaltransduktion (2)
- T-Lymphozyt (2)
- Tagesrhythmus (2)
- Taufliege (2)
- Tissue Engineering (2)
- Zelldifferenzierung (2)
- gp130 (2)
- miRNS (2)
- 3D-Kultur (1)
- 5-FU (1)
- ACL (1)
- ADHS (1)
- Acid adaptation (1)
- Acyrthosiphon pisum (1)
- Adenomatous-polyposis-coli-Protein (1)
- Aliphatics (1)
- Ameise (1)
- Ameisen (1)
- Angeborene Immunität (1)
- Animal behavior IntelliCage system (1)
- Animal model (1)
- Ant (1)
- Antigen CD28 (1)
- Antigen CD8 (1)
- Antikörper-Antwort (1)
- Anxiety (1)
- Aorta (1)
- Apis mellifera (1)
- Arbeitsgedächtnis (1)
- ArsZ (1)
- Arzneimitteldesign (1)
- Aspergillose (1)
- AstA (1)
- Atherosclerosis (1)
- Atta vollenweideri (1)
- Aurora-A (1)
- Autoantikörper (1)
- B-Lymphozyt (1)
- Bacillus subtilis (1)
- Bacteria (1)
- Bacterial infection (1)
- Bakterien (1)
- Bakteriophagen (1)
- Bildverarbeitung (1)
- BioVaSc (1)
- Biofilm formation (1)
- Biofilms (1)
- Bioinformatics (1)
- Bioinformatik (1)
- Biologie (1)
- Bipolar Disorder (1)
- Bisphosphonate (1)
- Blut-Hirn-Schranke (1)
- Blutstammzelle (1)
- Bone (1)
- Brain-derived neurotrophic factor (1)
- Bäckerhefe (1)
- Bärtierchen (1)
- C. albicans (1)
- CD28 (1)
- CD4+ (1)
- CD8 Effektorfunktionen (1)
- CD8 Gedächtnisreaktionen (1)
- CDH13 (1)
- CIDP (1)
- CLEC-2 (1)
- CRHR1 (1)
- CRISPR/Cas9 (1)
- CXCL13 (1)
- Cadherin 13 (1)
- Cadherin-13 (1)
- Calcium (1)
- Camponotus (1)
- Camponotus floridanus (1)
- Cancer (1)
- Cancer models (1)
- Cancer therapeutic resistance (1)
- Cartilage Regeneration (1)
- Caspr-1 (1)
- Catechol-0-Methyltransferase (1)
- Cell differentiation (1)
- Ceramides (1)
- Chain-length distribution (1)
- Chemoresistenz (1)
- Chemotherapeutic resistance (1)
- Chimeric antigen receptor (1)
- Chlamydia (1)
- Chlamydienkrankheit (1)
- Chromatin (1)
- Chronobiologie (1)
- Chronophin (1)
- Circadian Clock (1)
- Circadiane Uhr (1)
- Circadianer Rhythmus (1)
- Coffin-Lowry syndrome (1)
- Colonkrebs (1)
- Computational drug design (1)
- Contactin-1 (1)
- Corticoliberin (1)
- Cuticle (1)
- Cuticular water permeabilities (1)
- Cuticular waxes (1)
- Cyclics (1)
- DNA Sekundärstruktur (1)
- DNA secondary structure (1)
- DNS-Bindungsproteine (1)
- DNS-Reparatur (1)
- DRG (1)
- Dendritic cells (1)
- Dendritische Zelle (1)
- Depression (1)
- Diabetes mellitus (1)
- Differenzierungszustand (1)
- Drosophila (1)
- Drosophila Myc transcription growth PAF1 (1)
- Dualstere Liganden (1)
- Dualsteric Ligands (1)
- E. coli Nissle 1917 (1)
- EHEC (1)
- ELISA (1)
- Efflux pump (1)
- Einzelzellgelelektrophorese (1)
- Elektroencephalogramm (1)
- Emotion (1)
- Empfindlichkeit (1)
- Endogenous clock (1)
- Endozytose (1)
- Enoyl-acyl-carrier-protein-Reductase <Enoyl-[acyl-carrier-protein]-Reductase> (1)
- Enterohemorrhagic Escherichia coli (1)
- Entwicklung chimärer Antigenrezeptor T-Zellen (1)
- Entzündung (1)
- Entzündungsschmerz (1)
- Enzyminhibitor (1)
- Extracellular matrix proteins (1)
- Extrazelluläre Matrix (1)
- Fabry-Krankheit (1)
- Farbensehen (1)
- Feedforward loop (1)
- Fluconazole (1)
- Fluorescence (1)
- Fluorescence Microscopy (1)
- Fluorescence Resonance Energy Transfer (1)
- Fluoreszenzmikroskopie (1)
- Fruit (1)
- Furcht (1)
- G Protein-Coupled Receptors (1)
- GABAerge Nervenzelle (1)
- GLP-1 (1)
- GPCR (1)
- GPVI (1)
- Galactosidase <alpha-> (1)
- Gb3 accumulation (1)
- Gefühl (1)
- Gehirn (1)
- Generalisierung (1)
- Generalization (1)
- Genetics (1)
- Genexpression (1)
- Genom (1)
- Genome editing (1)
- Genomeditierung (1)
- Genotoxizität (1)
- Genregulation (1)
- Geruchssinn (1)
- Glottoplastik (1)
- Glutamin (1)
- Glycoprotein GPV (1)
- Golgi-Apparat (1)
- Guillain-Barré-Syndrom (1)
- HP1432, Hpn2 (1)
- Helicobacter pylori (1)
- Hematopoietic Stem Cell (1)
- Hemostasis (1)
- Herzinfarkt (1)
- Heubacillus (1)
- Hic-5 (1)
- Histatin 5 (1)
- Hospitalismus <Hygiene> (1)
- Host defense (1)
- Host-pathogen interaction (1)
- Hyaluronic acid (1)
- Hyaluronsäure (1)
- Hydrogel (1)
- Hämatopoetische Stammzellen (1)
- IFN-g (1)
- IL-23 (1)
- IgG-Subklasse (1)
- Image Processing (1)
- Immune Thrombocytopenia (1)
- Immunglobulin G (1)
- Immunsystem (1)
- Immuntherapie (1)
- Immunthrombozytopenie (1)
- Inhibition (1)
- Innate immunity (1)
- Innere Uhr (1)
- Insect (1)
- Insekt (1)
- Interaktion (1)
- Interferon <gamma-> (1)
- Interleukin 2 (1)
- Interleukin 6 (1)
- Interleukine (1)
- Intestinal stem cell (1)
- Intratumorale Heterogenität (1)
- Ion channel function (1)
- Ionenkanal (1)
- Ischemic stroke (1)
- Kation (1)
- Kehlkopfchirurgie (1)
- Kernspintomografie (1)
- Klima (1)
- Knochenmark (1)
- Knockout (1)
- Knockout <Molekulargenetik> (1)
- Knorpel (1)
- Kohlendioxid (1)
- Kommunikation (1)
- Komplement <Immunologie> (1)
- Komplexauge (1)
- Konditionierung (1)
- Kostimulation (1)
- Krebs <Medizin> (1)
- Krebsimmuntherapie (1)
- LAD (1)
- Lactatdehydrogenase (1)
- Lambdoide Prophagen (1)
- Leaf (1)
- Lgr5 (1)
- MDR1 (1)
- MIPs (1)
- MMN (1)
- MRI (1)
- MRR1 (1)
- MRT (1)
- MYC (1)
- Magnetic resonance imaging (1)
- Manisch-depressive Krankheit (1)
- Marine sponge-derived actinomycetes (1)
- Marine sponges (1)
- Marrow (1)
- Massenspektrometrie/Proteomics (1)
- Mediator Komplex (1)
- Megakaryocyte (1)
- Megakaryocytes (1)
- Megakaryozyt (1)
- Mek5/Erk5-Signalweg (1)
- Melanom (1)
- Melanoma (1)
- Membranlipide (1)
- Merkel cell carcinoma (1)
- Merkelzellkarzinom (1)
- Mesenchymal Stem Cell (1)
- Mesenchymal Stromal Cells (1)
- Metabolic Labeling (1)
- MicroRNAs (1)
- Mikrokerne (1)
- Mitochondria (1)
- Mitochondrium (1)
- Model (1)
- Model simulation (1)
- Mrr1 (1)
- Multicellular aggregates (1)
- Multidrug-Resistance-Related Proteine (1)
- Multizellulären Bakteriengemeinschaften (1)
- Muscarinrezeptor (1)
- Muskelzelle (1)
- Mutagenität (1)
- Mycobacterium tuberculosis (1)
- Mycobacterium tuberculosis InhA (1)
- N-MYC (1)
- NIR-Spektroskopie (1)
- NOS-I (1)
- NOS1AP (1)
- NaV1.9. oxidized phospholipids (1)
- Nahrungsaufnahme (1)
- Nestbau (1)
- Netzhaut (1)
- Neuroanatomie (1)
- Neurobiologie (1)
- Neurobiology (1)
- Neurodevelopment (1)
- Neuronale Plastizität (1)
- Neutrophils (1)
- Nodo-Paranodopathie (1)
- Non-coding RNA (1)
- Non-viral genome engineering (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- OCT1 (1)
- OSM (1)
- OSMR (1)
- Olfaction (1)
- Oncostatin M (1)
- Onkogen (1)
- PDXP (1)
- Panic Disorder (1)
- Paniksyndrom (1)
- Partial Agonists (1)
- Partialagonismus (1)
- Pathogenität (1)
- Peptide (1)
- Permeability (1)
- Phonochirurgie (1)
- Phosphatase (1)
- Phospholipase D (1)
- Phospholipide (1)
- Plasmonic (1)
- Platelet (1)
- Poly(glycidol) (1)
- Polyneuropathie (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Post-transcriptional regulation (1)
- Pra1 (1)
- Probiotikum (1)
- Protein (1)
- Protein folding (1)
- Protein-Protein Interaktion (1)
- Proteom (1)
- Proteomics (1)
- Psychische Störung (1)
- Pyrrolidinderivate (1)
- Pyrrolidine carboxamides (1)
- RAF Kinasen (1)
- REST-Complex (1)
- RNA polymerase II (1)
- RNA sequencing (1)
- RNA-binding proteins (1)
- RNS (1)
- RSK2 (1)
- Ranvier-Schnürring (1)
- Raphe Kerne (1)
- Regulator of G protein signaling 2 (1)
- Rekonstruktion (1)
- Rezeptor (1)
- Rgs2 (1)
- Rho-Proteine (1)
- RhoGTPase (1)
- Rituximab (1)
- SIS-muc (1)
- SOCE (1)
- Saccharomyces cerevisiae (1)
- Schilddrüse (1)
- Schlaf (1)
- Schmerz (1)
- Sekundärstruktur (1)
- Sequenzanalyse <Chemie> (1)
- Serotonerge Nervenzelle (1)
- Serotonin (1)
- Sglt1 (1)
- Shigella flexneri (1)
- Simulation (1)
- Sleeping Beauty transposon (1)
- Small RNA (1)
- Soziale Insekten (1)
- Spatiotemporal analysis (1)
- Speicheldrüse (1)
- Sphingomyelinase (1)
- Spleen tyrosine kinase (1)
- Stammzelle (1)
- Staphylococci (1)
- Staphylococcus epidermidis (1)
- Stathmin (1)
- Stickstoffmonoxid-Synthase (1)
- Stimmbandchirurgie (1)
- Stimmerhöhung (1)
- Stofftransport <Biologie> (1)
- Streptomyces (1)
- Stressresistenz (1)
- Structure-based (1)
- Säugerzellen (1)
- Säugetiere (1)
- T-Zelle (1)
- T-cell engineering (1)
- T-cell therapy (1)
- TFIIIC (1)
- TRPA1 (1)
- TRPV1 (1)
- Tagesrhythmik (1)
- Targeted therapies (1)
- Thrombopoese (1)
- Thrombopoiesis (1)
- Thrombosis (1)
- Thrombozytenaggregation (1)
- Tiermodell (1)
- Timing (1)
- Transcriptome (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transpiration barrier (1)
- Transporters (1)
- Transposon (1)
- Transsexualismus (1)
- Tripartite Model (1)
- TrkB (1)
- Tropomyosin receptor kinase B (1)
- Trypanosoma brucei (1)
- Tuberkelbakterium (1)
- Tumor-Nekrose-Faktor <alpha> (1)
- Tumormetabolismus (1)
- Tumorzellen (1)
- Tumour angiogenesis (1)
- VSMC (1)
- Venusfliegenfalle (1)
- Verhalten (1)
- Virulenzfaktor (1)
- Voltage-Clamp-Methode (1)
- Wasser Fett Trennung (1)
- Xerostomie (1)
- adulte Neurogenese (1)
- airflow (1)
- antivirale Gene (1)
- anxiety (1)
- artificial diet (1)
- bSSFP (1)
- balanced steady state free precession (1)
- bees (1)
- behavioral rhythms (1)
- behaviour (1)
- bioinformatics (1)
- biomedical applications (1)
- biomedicine (1)
- blood glucose regulation (1)
- blood-brain barrier (1)
- bone marrow niche (1)
- brood rearing (1)
- building behavior (1)
- cancer (1)
- carbon dioxide (1)
- chronophin (1)
- circadian clocks (1)
- climate change (1)
- climate control (1)
- cohesin (1)
- color vision (1)
- comet assay (1)
- compound eyes (1)
- defense (1)
- dendritische Zelle (1)
- differentiation status (1)
- division of labor (1)
- early neural precursors (1)
- early-life stress (1)
- ecology (1)
- electroencephalogram (1)
- emotion processing (1)
- enoyl ACP reductase (1)
- epigenetics (1)
- evolution (1)
- fear conditioning (1)
- fitness (1)
- flytrap (1)
- foraging (1)
- frequency modulation (1)
- frühe neurale Vorläufer (1)
- genomics (1)
- genotoxic agents (1)
- genotoxische Agenzien (1)
- glucose (1)
- glycoprotein GPV (1)
- hibernation (1)
- human primary cells (1)
- icaADBC (1)
- inflammatory pain (1)
- insertion-site deep sequencing (1)
- insulin (1)
- intravenöse Immunglobuline (1)
- islets of Langerhans (1)
- jasmonate (1)
- lambdoid prophage (1)
- leaf-cutting ants (1)
- lipid rafts (1)
- mammalian cells (1)
- mass spectrometry (1)
- metabolism (1)
- miR-26 (1)
- miRNA Biogenesis (1)
- micronuclei (1)
- microrna (1)
- mouse platelets (1)
- ncRNA (1)
- near-infrared spectroscopy (1)
- nest climate (1)
- neuroblastoma (1)
- neuroepithelial progenitors (1)
- neuroepitheliale Vorläufer (1)
- neurogenesis (1)
- neuronal nitric oxide synthase (1)
- neuronale Stickstoffmonoxidsynthase (1)
- neuropsychiatric disorders (1)
- neuropsychiatrische Störungen (1)
- nicht-viraler Gentransfer (1)
- non-coding RNA (1)
- nuclesosome positioning (1)
- oxidierte Phospholipide (1)
- pancreas (1)
- pdxp (1)
- pea aphid (1)
- phosphatase (1)
- phospholipase D (1)
- platelet (1)
- platelet biogenesis (1)
- platelets (1)
- postradiogene Xerostomie (1)
- probiotica (1)
- progenitors (1)
- pyrrolidine carboxamides (1)
- rac1 inhibitors (1)
- reconstruction (1)
- research software (1)
- retinal development (1)
- rodent model (1)
- secretion (1)
- splicing (1)
- stem cells (1)
- store-operated calcium entry (1)
- stroke (1)
- stx-Phagen (1)
- stx-phages (1)
- synthetic lethal interaction (1)
- synthetisch lethale Interaktion (1)
- temperate zones (1)
- temporal organization (1)
- thyroid stimulating hormone receptor (1)
- timing (1)
- trans-Golgi network (1)
- transcriptome (1)
- tumorspezifische Therapie (1)
- varroa (1)
- vaskuläre glatte Muskelzelle (1)
- venus (1)
- waggle dance (1)
- water fat separation (1)
- wild bees (1)
- working memory (1)
- zeitgeber (1)
- zeitliche Organisation (1)
Institute
- Graduate School of Life Sciences (81) (remove)
Sonstige beteiligte Institutionen
- Expertenkreis zur Erarbeitung eines Stufenplans zur Diagnose und Therapie von Angsterkrankungen (1)
- Hans-Knöll-Institut Jena (1)
- Harvard Medical School, Boston, USA (1)
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Würzburg (1)
- Lehrstuhl für Tierökologie und Tropenbiologie, Universität Würzburg (1)
- Maastricht University, Department of Psychiatry and Neuropsychology (1)
- Universität Jena (1)
- Zentrum für Infektionsforschung (ZINF) Würzburg (1)
- Zentrum für Infektionsforschung ZINF Würzburg (1)
New experimental methods have drastically accelerated the pace and quantity at which biological data is generated. High-throughput DNA sequencing is one of the pivotal new technologies. It offers a number of novel applications in various fields of biology, including ecology, evolution, and genomics. However, together with those opportunities many new challenges arise. Specialized algorithms and software are required to cope with the amount of data, often requiring substantial training in bioinformatic methods. Another way to make those data accessible to non-bioinformaticians is the development of programs with intuitive user interfaces.
In my thesis I developed analyses and programs to tackle current problems with high-throughput data in biology. In the field of ecology this covers the establishment of the bioinformatic workflow for pollen DNA meta-barcoding. Furthermore, I developed an application that facilitates the analysis of ecological communities in the context of their traits. Information from multiple public databases have been aggregated and can now be mapped automatically to existing community tables for interactive inspection. In evolution the new data are used to reconstruct phylogenetic trees from multiple genes. I developed the tool bcgTree to automate this process for bacteria. Many plant genomes have been sequenced in current years. Sequencing reads of those projects also contain data from the chloroplasts. The tool chloroExtractor supports the targeted extraction and analysis of the chloroplast genome. To compare the structure of multiple genomes specialized software is required for calculation and visualization of the relationships. I developed AliTV to address this. In contrast to existing programs for this task it allows interactive adjustments of produced graphics. Thus, facilitating the discovery of biologically relevant information. Another application I developed helps to analyze transcriptomes even if no reference genome is present. This is achieved by aggregating the different pieces of information, like functional annotation and expression level, for each transcript in a web platform. Scientists can then search, filter, subset, and visualize the transcriptome.
Together the methods and tools expedite insights into biological systems that were not possible before.
Humans are continuously exposed to airborne spores of the saprophytic fungus Aspergillus fumigatus. In healthy individuals, local pulmonary host defence mechanisms can efficiently eliminate the fungus without any overt symptoms. In contrast, A. fumigatus causes devastating infections in immunocompromised patients. However, local host immune responses against A. fumigatus lung infections in immunocompromised conditions have remained largely elusive.
Given the dynamic changes in immune cell subsets within tissues upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune response after A. fumigatus infection to reveal basic immunological events that fail to effectively control the invasive fungal disease. In different immunocompromised murine models, myeloid but not lymphoid cells were strongly recruited upon infection. Notably, neutrophils and macrophages were recruited to infected lungs in different immunosuppressed regimens. Other myeloid cells, particularly dendritic cells and monocytes were only recruited in the corticosteroid model after infection. Lymphoid cells, particularly CD4+ or CD8+ T-cells and NK cells were highly reduced upon immunosuppression and were not recruited after A. fumigatus infection. Importantly, adoptive CD11b+ myeloid cell transfer rescued immunosuppressed mice from lethal A. fumigatus infection. These findings illustrate that CD11b+ myeloid cells are critical for anti-A. fumigatus defence under immunocompromised conditions.
Despite improved antifungal agents, invasive A. fumigatus lung infections cause a high rate morbidity and mortality in neutropenic patients. Granulocyte transfusions have been tested as an alternative therapy for the management of high-risk neutropenic patients with invasive A. fumigatus infections. To increase the granulocyte yield for transfusion, donors are treated with corticosteroids. Yet, the efficacy of granulocyte transfusion and the functional defence mechanisms of granulocytes collected from corticosteroid treated donors remain largely elusive.
We aimed to assess the efficacy of granulocyte transfusion and functional defence mechanisms of corticosteroid treated granulocytes using mouse models.
In this thesis, we show that transfusion of granulocytes from corticosteroid treated mice did not protect cyclophosphamide immunosuppressed mice against lethal A. fumigatus infection in contrast to granulocytes from untreated mice. Upon infection, increased levels of inflammatory cytokines helped to recruit granulocytes to the lungs without any recruitment defects in corticosteroid treated and infected mice or in cyclophosphamide immunosuppressed and infected mice that have received the granulocytes from corticosteroid treated mice. However, corticosteroid treated human or mouse neutrophils failed to form neutrophil extracellular traps (NETs) in in vitro and in vivo conditions. Further, corticosteroid treated granulocytes exhibited impaired ROS production against A. fumigatus. Notably, corticosteroids impaired the β-glucan receptor Dectin-1 (CLEC7A) on mouse and human granulocytes to efficiently recognize and phagocytize A. fumigatus, which markedly impaired fungal killing. We conclude that corticosteroid treatment of granulocyte donors for increasing neutrophil yields or patients with ongoing corticosteroid treatment could result in deleterious effects on granulocyte antifungal functions, thereby limiting the benefit of granulocyte transfusion therapies against invasive fungal infections.
Fluorescence microscopy has become one of the most important techniques for the imaging of biological cells and tissue, since the technique allows for selective labeling with fluorescent molecules and is highly suitable for low-light applications down to the single molecule regime. The methodological requirements are well-defined for studying membrane receptors within a highly localized nanometer-thin membrane. For example, G-protein-coupled receptors (GPCRs) are an extensively studied class of membrane receptors that represent one of the most important pharmaceutical targets. Ligand binding and GPCR activation dynamics are suspected to take place at the millisecond scale and may even be far faster. Thus, techniques that are fast, selective, and live-cell compatible are required to monitor GPCR dynamics. Fluorescence resonance energy transfer (FRET) and total internal reflection fluorescence microscopy (TIRF-M) are methods of choice to monitor the dynamics of GPCRs selectively within the cell membrane.
Despite the remarkable success of these modalities, there are limitations. Most importantly, inhomogeneous illumination can induce imaging artifacts, rendering spectroscopic evaluation difficult. Background signal due to scattering processes or imperfect labeling can hamper the signal-to-noise, thus limiting image contrast and acquisition speed. Careful consideration of the internal physiology is required for FRET sensor design, so that ligand binding and cell compatibility are well-preserved despite the fluorescence labeling procedures. This limitation of labeling positions leads to very low signal changes in FRET-based GPCR analysis. In addition, microscopy of these systems becomes even more challenging in single molecule or low-light applications where the accuracy and temporal resolution may become dramatically low. Fluorescent labels should therefore be brighter, protected from photobleaching, and as small as possible to avoid interference with the binding kinetics. The development of new fluorescent molecules and labeling methods is an ongoing process. However, a complete characterization of new labels and sensors takes time. So far, the perfect dye system for GPCR studies has not been found, even though there is high demand.
Thus, this thesis explores and applies a different approach based on improved illumination schemes for TIRF-M as well as metal-coated coverslips to enhance fluorescence and FRET efficiency. First, it is demonstrated that a 360° illumination scheme reduces typical TIRF artifacts and produces a much more homogenously illuminated field of view. Second, membrane imaging and FRET spectroscopy are improved by metal coatings that are used to modulate the fluorescent properties of common fluorescent dyes. Computer simulation methods are used to understand the underlying photophysics and to design the coatings. Third, this thesis explores the operational regime and limitations of plasmonic approaches with high sectioning capabilities. The findings are summarized by three publications that are presented in the results section of this work. In addition, the theory of fluorescence and FRET is explained, with particular attention to its emission modulations in the vicinity of metal-dielectric layers. Details of the instrumentation, computer simulations, and cell culture are described in the method section. The work concludes with a discussion of the findings within the framework of recent technological developments as well as perspectives and suggestions for future approaches complete the presented work.
In der vorliegenden Arbeit wurden die Einflüsse verschiedener genotoxischer Substanzen auf Säugertierzellen untersucht. Da ein Organismus der Ontogenese unterliegt und sich Zellen aus Stamm- und Vorläuferzellen entwickelt, gilt es diese ursprünglichen Zellen vor äußeren Einflüssen zu schützen. Da bisher kaum Untersuchungen von Zellen in verschiedenen Differenzierungsstadien durchgeführt wurden, wurden unter Verwendung vieler unterschiedlicher biologischer Endpunkte Effekte auf die Vitalität, Proliferation, Mitose und Apoptose dieser Zellen untersucht. Zudem erfolgte eine Interpretation der Ausbildung von Mikrokernen, Entstehung von DNS-Schäden und der zugrundeliegenden Reparaturmechanismen.
So konnte mit Hilfe der Untersuchungen der hämatopoetischen Stammzellen und der TK6-Zellen postuliert werden, dass hämatopoetische Stammzellen weitestgehend weniger empfindlich gegenüber Zytostatika (Doxorubicin, Vinblastin, Methylmethansulfonat und Mitomycin C) sind als die lymphoblastoide Zelllinie TK6, welche in der Entwicklungshierarchie den Stammzellen folgt. Die Befürchtung, dass der Mikrokerntest in immortalisierten TK6-Zellen als Grundlage für Genotoxizitätsuntersuchungen nicht genügen würden, konnte mit Hilfe der Versuchsergebnisse dieser Arbeit widerlegt werden. Die Ergebnisse belegen, dass der Mikrokerntest in TK6-Zellen relevant ist, da TK6-Zellen empfindlicher auf genotoxische Agentien im Vergleich zu hämatopoetischen Stammzellen reagieren.
Bei der Untersuchung der Leukämiezelllinie HL-60 wurden die Effekte klassischer (Vinblastin, Vincristin, Vinflunin und Vinorelbin) mit neu synthetisierten Vinca-Alkaloiden (4-Chlorochablastin, 4-Chlorochacristin, 16a, 17b und 18a) verglichen. Vinca-Alkaloide werden sehr häufig mit Nebenwirkungen, wie Neuropathien assoziiert, welche während einer Chemotherapie oftmals zu Therapieabbrüchen durch die Patienten führen. Aus diesem Grund war es erstrebenswert, neuartige Vinca-Alkaloide zu entwickeln, welche weniger Nebenwirkungen aber zugleich eine ähnliche Wirksamkeit aufweisen. Obwohl die Potenz der neuen Substanzen niedriger war als bei Vinblastin, Vincristin und Vinorelbin, zeigte ein Teil eine ähnliche Wirkung wie das Vinca-Alkaloid Vinflunin auf die Krebszelllinie HL-60 auf. Die Ergebnisse diese Arbeit können als erste Indikation in vitro genommen werden, dass sich diese Substanzen in der Krebstherapie als wirksam erweisen könnten und nach weiteren Ergebnissen in vivo als therapeutische Alternativen in Betracht gezogen werden.
Auch bei der vergleichenden Untersuchung von exponentiell wachsenden mit differenzierten Zelllinien konnten Unterschiede detektiert werden. Die Zelllinie HT-22, welche selbst keine Krebszelllinie ist, zeigte nach Differenzierung zu nicht exponentiell wachsenden Zellen eine erhöhte Empfindlichkeit gegenüber dem Alkylanz Methylmethansulfonat, was auf einer verminderten Basenexzisionsreparatur beruhen könnte. Auch die differenzierte Form der Adenokarzinom-Zelllinie CaCo2 zeigte eine gesteigerte Sensitivität gegenüber dem Topoisomerase II-Inhibitor Etoposid auf, wohingegen der unselektive Topoisomerase II-Hemmer Doxorubicin keinen Effekt aufwies. Um den Sachverhalt zu klären ob die festgestellten Unterschiede auf das Enzym Topoisomerase II zurückzuführen oder zellartspezifisch waren, wurden weitere Analysen der Zelllinien HL-60 und deren differenzierten Zellart durchgeführt. Auch hier konnten signifikante Unterschiede bei der Einzelzellgelelektrophorese nach Behandlung mit Doxorubicin und Etoposid festgestellt werden. Neben den in dieser Arbeit nachgewiesenen Unterschieden bei der Reparatur zwischen den Zelltypen, könnten aber auch weitere Faktoren zu Varianzen führen und die Mutagenitätsforschung beeinflussen. Folglich ist davon auszugehen, dass zukünftige Testungen bei der pharmakologischen Substanzentwicklung in verschiedenen Zellsystemen von Nöten sind, bevor neue Substanzen zugelassen werden.
Alles in allem konnte die Komplexität der Ergebnisse zwischen Zellen der verschiedenen Differenzierungsstadien in dieser Arbeit aufgezeigt werden. Deswegen sollte auch bei weiteren Forschungsvorhaben insbesondere ein Augenmerk auf den Differenzierungszustand der zu untersuchenden Zellpopulation geworfen werden.
Platelets, small anucleated blood cells responsible for hemostasis, interact at sights of injury with several exposed extracellular matrix (ECM) proteins through specific receptors. Ligand binding leads to activation, adhesion and aggregation of platelets. Already megakaryocytes (MKs), the immediate precursor cells in bone marrow (BM), are in constant contact to these ECM proteins (ECMP). The interaction of ECMP with MKs is, in contrast to platelets, less well understood. It is therefore important to study how MKs interact with sinusoids via the underlying ECMP. This thesis addresses three major topics to elucidate these interactions and their role in platelet biogenesis.
First, we studied the topology of ECMP within BM and their impact on proplatelet formation (PPF) in vitro. By establishing a four-color immunofluorescence microscopy we localized collagens and other ECMP and determined their degree of contact towards vessels and megakaryocytes (MKs). In in vitro assays we could demonstrate that Col I mediates increased MK adhesion, but inhibits PPF by collagen receptor GPVI. By immunoblot analyses we identified that the signaling events underyling this inhibition are different from those in platelet activation at the Src family kinase level.
Second, we determined the degree of MK-ECM interaction in situ using confocal laser scanning microscopy of four-color IF-stained femora and spleen sections. In transgenic mouse models lacking either of the two major collagen receptors we could show that these mice have an impaired association of MKs to collagens in the BM, while the MK count in spleen increased threefold. This might contribute to the overall unaltered platelet counts in collagen receptor-deficient mice.
In a third approach, we studied how the equilibrium of ECMP within BM is altered after irradiation. Collagen type IV and laminin-α5 subunits were selectively degraded at the sinusoids, while the matrix degrading protease MMP9 was upregulated in MKs. Platelet numbers decreased and platelets became hyporesponsive towards agonists, especially those for GPVI activation.
Taken together, the results indicate that MK-ECM interaction differs substantially from the well-known platelet-ECM signaling. Future work should further elucidate how ECMP can be targeted to ameliorate the platelet production and function defects, especially in patients after BM irradiation.
Interleukin-6 (IL-6)-Typ Zytokine, allen voran IL-6 und Oncostatin M (OSM), besitzen pleiotrope Eigenschaften und spielen eine wichtige Rolle bei einer Vielzahl biologischer Prozesse. Als Akutphaseinduktoren sind IL-6 und OSM an der Initialisierung entzündlicher und immunologischer Prozesse beteiligt, können aber ebenso die Differenzierung und das Zellwachstum beeinflussen. Ihre biologische Wirkung vermitteln sie über die Bindung an einen multimeren Rezeptorkomplex. Dieser weist im Fall von IL-6 eine hexamere Struktur auf und besteht aus je zwei Molekülen des Glykoproteins 130 (gp130), des IL-6 α Rezeptors (IL-6R) und IL-6. Der Rezeptor von OSM hingegen ist ein Heterodimer und besteht aus gp130 und dem OSM Rezeptor (OSMR) oder aber aus gp130 und dem leukemia inhibitory factor (LIF) Rezeptor (LIFR). Die Zytokine der IL-6-Familie vermitteln die Induktion des Jak/STAT (Januskinase/signal transducer and activator of transcription), PI3K/Akt (Phosphoinositid-3-Kinasen/AKR thymoma oncogene homolog) und MAPK (mitogenaktivierte Proteinkinase) Signalwegs. Da eine unkontrollierte Aktivierung dieser Signalkaskaden jedoch zu chronisch entzündlichen Erkrankungen oder abnormen Zellwachstum führen kann, ist eine Regulation durch verschiedene Rückkopplungsmechanismen essentiell. Neben der Rekrutierung inhibitorisch wirkender Proteine, wie den Mitgliedern der SOCS (suppressors of cytokine signaling) Familie und Tyrosinphosphatasen, gilt die Rezeptorinternalisierung als regulierender Mechanismus.
Der erste Teil der vorliegenden Dissertation geht der Fragestellung nach, wie die Expression des IL-6-Rezeptors während der Differenzierung und Maturierung dendritischer Zellen (DZ) reguliert ist und welche Relevanz die gp130-Internalisierung bei diesen Entwicklungsprozessen spielt.
DZ gehören zu den professionellen antigenpräsentieren Zellen (APZ) und gelten als Bindeglied zwischen der angeborenen und adaptiven Immunantwort. Sie spielen insbesondere bei der Polarisation der T-Helferzellen (Th1, Th2, Th17, Treg) eine wichtige Rolle. DZ repräsentieren eine heterogene Zellpopulation, die auf Basis ihrer Entstehung, ihres Vorkommens und/oder ihrer Funktionen in verschiedene Subtypen unterteilt werden und sich u.a. durch die Expression bestimmter Oberflächenmarker unterscheiden lassen. Es ist bekannt, dass DZ sowohl gp130 als auch den IL-6R auf ihrer Oberfläche exprimieren, weshalb ihre Differenzierung und Maturierung durch IL-6 beeinflusst werden kann. Obwohl Studien der letzten Jahre bereits eindrucksvoll die Relevanz des IL-6-Signals für die DZ Entwicklung belegt haben, bleibt dessen Funktion für diese Prozesse bisher kontrovers diskutiert. Inwiefern eine veränderte Rezeptorexpression auf diesen Zellen Einfluss auf die biologische Wirkung von IL-6 nimmt, wurde bisher nicht untersucht und war daher Ziel der hier durchgeführten Experimente. Mit Hilfe GM-CSF-gereifter DZ aus murinem Knochenmark (KM-DZ) sowie steady state DZ aus peripheren lymphatischen Organen konnte gezeigt werden, dass die Expression von gp130 und IL-6R bereits während der DZ Differenzierung unterschiedlich reguliert ist. Konventionelle DZ (kDZ) aus Milz und Lymphknoten wiesen ein höheres Expressionsniveau für den IL-6-Rezeptor auf als plasmazytoide DZ (pDZ). Es wurde nachgewiesen, dass die gp130 Expression im Verlauf der DZ Differenzierung stetig zunimmt, während nahezu keine Veränderung für die Expression des IL-6R festzustellen war. In weiteren Experimenten konnte darüber hinaus belegt werden, dass die Reifung der DZ, induziert durch Lipopolysaccharid (LPS), Tumornekrosefaktor-α (TNFα) oder Choleratoxin (Ctx), zu einer Cross-Regulation von gp130 führt. Diese konnte im Fall von TNFα und Ctx auf eine vorübergehende Internalisierung des Rezeptors in Folge der Aktivierung der Serin-/Threonin-Kinase MK2 (MAPK-aktivierte Proteinkinase 2) zurückgeführt werden. Untersuchungen von KM-DZ aus der gp130 knockin Mauslinie gp130LLAA, die sich durch eine Punktmutation des beschriebenen Endozytose-Motivs des Rezeptors auszeichnet, führten zu dem Schluss, dass LPS gp130 über einen bisher noch nicht beschriebenen Mechanismus reguliert. Dieser vermittelt eine frühe Clathrin-abhängige Internalisierung von gp130 und führt schließlich zu einer langfristigen Inhibierung der gp130 Expression. Die Regulation der IL-6 Rezeptorexpression ist insofern von Bedeutung als dass vermutet werden kann, dass das IL-6/STAT3-Signal für die Aufrechterhaltung eines unreifen DZ Phänotyps wichtig ist. Ferner kann vermutet werden, dass die Limitierung der Responsivität gegenüber LIF (und vermutlich auch OSM) für die Differenzierung von DZ wichtig ist, da die Expression des LIFR über die Dauer der KM-DZ Differenzierung stark herunterreguliert wurde. Eine Expression des OSMR auf DZ wurde hingegen nicht nachgewiesen und steht demzufolge im Gegensatz zu bisher veröffentlichten Untersuchungen.
Im Rahmen dieses ersten Projekts wurde ebenfalls untersucht, wie sich die veränderte gp130 Endozytose auf die Homöostase myeloider und lymphoider Zellen auswirkt. Bei den hierfür analysierten gp130LLAA Mäusen wurde eine geringfügige Verminderung der Frequenz und absoluten Zellzahl von kDZ in der Milz sowie eine Zunahme der Frequenz und absoluten Zellzahl von pDZ und Makrophagen in den inguinalen Lymphknoten nachgewiesen. Darüber hinaus wurde ein Anstieg in der Frequenz und absoluten Zellzahl von T-Zellen, jedoch eine Abnahme der B-Zellen in der Milz beobachtet.
Im zweiten Teil der Dissertation sollte die OSM-vermittelte Induktion antiviraler Gene in primären humanen dermalen Fibroblasten (HDF) untersucht werden.
Typ I Interferone (IFN) gelten als zentrale Zytokine der antiviralen Immunantwort. Studien der letzten Jahre haben gezeigt, dass eine Reihe proinflammatorischer Zytokine ebenso die antivirale Immunantwort beeinflussen können, indem sie u.a. die Expression der pattern recognition receptors (PRR) regulieren. PRR sind Teil des angeborenen Immunsystems und für die Erkennung von Pathogenen durch die Bindung an konservierte Pathogen-assoziierte molekulare Strukturen (PAMPs, Pathogen-associated molecular patterns) wichtig. Im zweiten Teilprojekt der vorliegenden Arbeit konnte gezeigt werden, dass OSM dazu in der Lage ist, die Induktion der im Zytoplasma lokalisierten PRR Retinoic acid inducible gene-I (RIG-I) und Melanoma differentiation-associated protein 5 (MDA5) zu vermitteln. Mit Hilfe von RNA Interferenzstudien konnte nachgewiesen werden, dass die Expression dieser beiden RNA-Helikasen von der OSM-vermittelten STAT1 Aktivierung abhängig ist und über einen STAT3/SOCS3-abhängigen Mechanismus reguliert wird. Während die Blockade der STAT1 Expression zu einer Inhibierung der OSM-induzierten Expression der Helikasen führte, wurde durch den Verlust von STAT3 oder SOCS3 die Expression von RIG-I und MDA5, aufgrund einer stärkeren und länger anhaltenden STAT1-Phosphorylierung, signifikant erhöht. Zusätzlich konnte ein additiver Effekt zwischen der OSM- und IFNγ-vermittelten Helikasenexpression belegt werden. Dieses Resultat steht im Einklang mit vorhergehenden Veröffentlichungen, die einen Crosstalk zwischen OSM und Typ I IFN bei der antiviralen Abwehr gegen das Hepatitis C Virus beschreiben.
This work considered the frequency-modulated balanced steady-state free precession (fm-bSSFP) sequence as a tool to provide banding free bSSFP MR images. The sequence was implemented and successfully applied to suppress bandings in various in vitro and in vivo examples. In combination with a radial trajectory it is a promising alternative for standard bSSFP applications. First, two specialized applications were shown to establish the benefits of the acquisition strategy in itself. In real time cardiac imaging, it was shown that the continuous shift in frequency causes a movement of the bandings across the FOV. Thus, no anatomical region is constantly impaired, and a suitable timeframe can be found to examine all important structures. Furthermore, a combination of images with different artifact positions, similar to phase-cycled acquisitions is possible. In this way, fast, banding-free imaging of the moving heart was realized. Second, acquisitions with long TR were shown. While standard bSSFP suffers from increasing incidence of bandings with higher TR values, the frequency-modulated approach provided banding free images, regardless of the TR.
A huge disadvantage of fm-bSSFP, in combination with the radial trajectory, is the decrease in signal intensity. In this work a specialized reconstruction method, the multifrequency reconstruction for frequency-modulated bSSFP (Muffm), was established, which successfully compensated that phenomena. The application of Muffm to several anatomical sites, such as inner ear, legs and cardiac acquisitions, proofed the advantageous SNR of the reconstruction.
Furthermore, fm-bSSFP was applied to the clinically highly relevant task of water-fat separation. Former approaches of a phase-sensitive separation procedure in combination with standard bSSFP showed promising results but failed in cases of high inhomogeneity or high field strengths where banding artifacts become a major issue. The novel approach of using the fm-bSSFP acquisition strategy with the separation approach provided robust, reliable images of high quality. Again, losses in signal intensity could be regained by Muffm, as both approaches are completely compatible.
Opposed to conventional banding suppression techniques, like frequency-scouts or phase-cycling, all reconstruction methods established in this work rely on a single radial acquisition, with scan times similar to standard bSSFP scans. No prolonged measurement times occur and patient time in the scanner is kept as short as possible, improving patient comfort, susceptibility to motion or physiological noise and cost of one scan.
All in all, the frequency-modulated acquisition in combination with specializes reconstruction methods, leads to a completely new quality of images with short acquisition times.
Bei der Entstehung und Aufrechterhaltung von Furcht und Angsterkrankungen stellt, neben der Furchtkonditionierung, die Generalisierung der konditionierten Furcht einen wesentlichen Mechanismus dar. Die der Generalisierung zugrunde liegenden psychologischen und biologischen Prozesse sind jedoch beim Menschen bisher nur wenig untersucht.
Ziel dieser Arbeit war, anhand eines neu entwickelten experimentellen Paradigmas den Einfluss eines psychometrisch bestimmbaren angstspezifischen Faktors sowie der mit Furcht und Angst assoziierten Genotypen Stathmin1, COMT Val158Met und BDNF Val66Met auf die Furchtkonditionierung und Generalisierung konditionierter Furcht zu untersuchen und somit mögliche Risikofaktoren für die Entstehung von Angsterkrankungen zu bestimmen. Hierfür wurden N = 126 gesunde Versuchspersonen (n = 69 weiblich; mittleres Alter M = 23.05, SD = 3.82) für die genannten Polymorphismen genotypisiert und zu ängstlichen und affektiven Symptomen befragt. In einer Akquisitionsphase wurden den Probanden zwei neutrale weibliche Gesichter präsentiert (CS), von denen eines mit einem Schrei sowie einem ängstlichen Gesichtsausdruck (UCS) gepaart wurde. Der sich anschließende Generalisierungstest erfolgte anhand von vier Gesichtern, die in der Ähnlichkeit zwischen den beiden CS schrittweise übergingen. Die Furchtreaktion wurde über die Bewertung von Valenz, Arousal und Kontingenzerwartung sowie über die Hautleitfähigkeitsreaktion (SCR) erfasst.
Die Analyse der Fragebögen anhand einer Hauptachsenanalyse und anhand von Strukturgleichungsmodellen erbrachte eine zweifaktorielle Lösung, die die Konstrukte Depression und Angst abbildete. Nur der Faktor Angst war mit einer veränderten Furchtkonditionierung und Furchtgeneralisierung assoziiert: Hoch Ängstliche zeigten eine stärkere konditionierte Furchtreaktion (Arousal) und wiesen eine stärkere Generalisierung der Valenzeinschätzung und Kontingenzerwartung auf. Für den Stathmin1 Genotyp ergaben sich geschlechtsspezifische Effekte. Bei den männlichen Versuchspersonen zeigte sich in Folge der Akquisition ein stärkerer Abfall der Valenz für den CS+ in der Gruppe der Stathmin1 T Allelträger, die ebenfalls eine stärkere Generalisierung der Furchtreaktion, abgebildet in allen verbalen Maßen, aufwiesen. Ein gegenteiliger Befund ergab sich für die Gruppe der Frauen, insofern eine mit dem Stathmin1 C Allel assoziierte höhere Generalisierung der Valenz, des Arousals und der Kontingenzerwartung festgestellt werden konnte. Für den COMT Val158Met Genotyp ergaben sich keine Einflüsse auf die Akquisition der konditionierten Furcht. Für Träger des COMT 158Val Allels zeigte sich jedoch eine stärkere Generalisierung der Valenz und der Kontingenzerwartung. Auch für den BDNF Val66Met Genotyp konnte keine Veränderung der Furchtakquisition beobachtet werden. Es ergaben sich jedoch Hinweise auf eine erhöhte Generalisierung der Kontingenzerwartung in der Gruppe der BDNF 66Val Homozygoten. Für keinen der beschriebenen Faktoren konnte ein Einfluss auf die Furchtkonditionierung oder deren Generalisierung anhand der SCR abgebildet werden.
Unsere Ergebnisse weisen auf einen psychometrisch erfassbaren Faktor und genetische Einflüsse hin, die über den Prozess einer stärkeren Generalisierung der konditionierten Furcht das Risiko für die Entstehung von Angsterkrankungen erhöhen können. Jedoch sollten die Befunde in größeren Stichproben repliziert werden. Neben der frühzeitigen Identifikation von Risikofaktoren sollten in zukünftigen Studien darüber hinaus wirksame Maßnahmen zur Prävention und Intervention entwickelt werden, um diesem Risiko entgegen zu wirken.
Recently, our research group identified in a study novel proalgesic targets in acute and chronic inflammatory pain: oxidized phospholipids (OxPL). OxPL, endogenous chemical irritants, are generated in inflamed tissue and mediate their pain-inducing function by activating the transient receptor potential channels TRPA1 and TRPV1. Both channels are sensors for chemical stimuli on primary afferent nociceptors and are involved in nociception. Here, with the help of calcium imaging and whole cell patch clamp recording techniques, it was found that OxPL metabolites acutely activate TRPA1 and TRPV1 ion channels to excite DRG neurons. OxPL species act predominantly via TRPA1 ion channels and mediate long- lasting non-selective inward currents. Notably, one pure OxPL compound, PGPC, activated a TRPA1 mutant lacking the binding site for electrophilic agonists, suggesting that OxPL activate TRP ion channels by an indirect mechanical mechanism. Next, it was investigated how OxPL influence the excitability of primary sensory neurons. Acute stimulation and fast calcium imaging revealed that OxPL elicit repetitive, spike-like calcium transients in small- diameter DRG neurons, which were fully blocked by antagonists against TRPA1/V1 and N- type voltage-gated calcium channels.
In search of a mechanism that drives repetitive spiking of DRG neurons, it was asked whether NaV1.9, a voltage-gated sodium channel involved in subthreshold excitability and nociception, is needed to trigger OxPL-induced calcium spikes and action potential firing. In electrophysiological recordings, both the combination of local application of OxPL and current injection were required to efficiently increase the action potential (AP) frequency of small-diameter sensory neurons. However, no difference was monitored in the resting membrane potential or OxPL-induced AP firing rate between wt and NaV1.9-deficient small diameter DRG neurons. To see whether NaV1.9 needs inflammatory conditions to be integrated in the OxPL-induced excitation cascade, sensory neurons were pretreated with a mixture of inflammatory mediators before OxPL application. Under inflammatory conditions both the AP and the calcium-spike frequency were drastically enhanced in response to an acute OxPL stimulus. Notably, this potentiation of OxPL stimuli was entirely lost in NaV1.9 deficient sensory neurons. Under inflammatory conditions, the resting membrane potential of NaV1.9-deficient neurons was more negative compared to wt neurons, suggesting that NaV1.9 shows resting activity only under inflammatory conditions.
In conclusion, OxPL are endogenous irritants that induce excitability in small-diameter DRG
neurons, a cellular model of nociceptors, via TRP activation. This effect is potentiated under inflammatory conditions. Under these conditions, NaV1.9 functions as essential mediator as it eases the initiation of excitability after OxPL stimulation.
As mutants in the human NaV1.9 mediate an enhanced or painless perception, this study provides new insight into the mechanism on how NaV1.9 amplifies stimuli of endogenous irritants under inflammatory conditions.
This work summarizes the results of studies on three major aspects of platelet signaling and of the pathogenesis of immune thrombocytopenia. Therefore, this thesis is divided into three parts. i) Platelet activation and subsequent thrombus formation at sites of vascular injury is crucial for normal hemostasis, but it can also trigger myocardial infarction and stroke. The initial capture of flowing platelets to the injured vessel wall is mediated by the interaction of the glycoprotein (GP) Ib-V-IX complex with von Willebrand factor (vWF) immobilized on the exposed subendothelial extracellular matrix (ECM). The central importance of GPIb for platelet adhesion is well established, whereas GPV is generally considered to be of minor relevance for platelet physiology and thrombus formation. This study intended to clarify the relevance of this receptor during thrombus formation using Gp5-/- mice and mice with different double-deficiencies in GPV and in other platelet receptors. It was found that GPV and the collagen receptor integrin a2b1 have partially redundant functions in collagentriggered platelet aggregation. Further, it was revealed that GPV limits thrombus formation and impairs hemostasis in vivo. The data presented here demonstrate that the protective effect of GPVI-deficiency (another platelet collagen receptor) in arterial thrombosis and ischemic stroke depends on the expression of GPV. Moreover, it was demonstrated that lack of GPV restores the hemostatic function of mice lacking both GPVI and a2b1 or mice lacking GPVI and the C-type lectin receptor 2 (CLEC-2). Conclusively, GPV-depletion or blockade might have the potential to treat hemorrhagic disease states. ii) Platelets contain the two phospholipase (PL) D isoforms, PLD1 and PLD2, both of which presumably become activated upon platelet stimulation. However, the function of PLD in the process of platelet activation and aggregation has not been definitively explored. Thus, PLD-deficient mice were analyzed. Mice lacking PLD1 or PLD2 were viable, fertile and had normal platelet counts. PLD1 was found to be responsible for the inducible PLD-activity in platelets and to contribute to efficient integrin activation under static conditions. Moreover, flow adhesion experiments revealed that PLD1 is essential for efficient GPIb-mediated integrin activation. Consequently, Pld1-/- mice were protected from arterial thrombosis and ischemic brain infarction without affecting tail bleeding times. Hence, inhibition of PLD1 might be a novel approach for antithrombotic therapy. iii) Cellular activation of platelets or immune cells results in increased cytosolic calcium (Ca2+) levels. Store-operated calcium entry (SOCE) via the STIM1-Orai1 axis is the main route of Ca2+ entry downstream of immunoreceptor tyrosine-based activating motif (ITAM) receptor stimulation in mast cells and T cells. However, the requirement of Ca2+-mobilization in Fcg receptor (FcgR)-signaling and the relevance of STIM2 for T cell SOCE have been unclear. To address these questions, genetically modified mice lacking central molecules of the SOCE machinery were analyzed. Ca2+-measurements revealed that both STIM isoforms contribute to Ca2+-mobilization downstream of T cell receptor activation. Additionally, it was found that FcgR stimulation results in SOCE and is mediated by STIM1 and probably Orai1. Animal models of immune thrombocytopenia (ITP) revealed that SOCE is essential for platelet clearance and that both STIM isoforms contribute to the pathology of ITP. Moreover, in this work it was also demonstrated that STIM1 and Orai1 are essential in IgG-mediated systemic anaphylaxis. STIM2 contributes to IgG-mediated, but not to IgE-mediated anaphylaxis. The data indicate that interference with SOCE might become a new strategy to prevent or treat IgG-dependent autoimmune diseases.
Marine sponge-associated actinomycetes are reservoirs of diverse natural products with novel biological activities. Their antibiotic potential has been well explored against a range of Gram positive and negative bacteria. However, not much is known about their anti-infective or anti-virulence potential against human pathogens. This Ph.D. project aimed to investigate the anti-infective (anti-Shiga toxin and anti-biofilm) potential of sponge-derived actinobacteria through identification and isolation of their bioactive metabolites produced and characterizing their mechanism of action by transcriptomics. This thesis is divided into three studies with the overall objective of exploring the anti-infective efficacy of actinomycetes-derived extracts and compound(s) that could possibly be used as future therapeutics.
The first study deals with investigation on the anti-Shiga toxin effects of sponge-associated actinomycetes. Diarrheal infections pose a huge burden in several developing and developed countries. Diarrheal outbreaks caused by Enterohemorrhagic Escherichia coli (EHEC) could lead to life-threatening complications like gastroenteritis and haemolytic uremic syndrome (HUS) if left untreated. Shiga toxin (Stx) produced by EHEC is a major virulence factor that negatively affects the human cells, leading them to death via apoptosis. Antibiotics are not prescribed against EHEC infections since they may enhance the risk of development of HUS by inducing the production and release of Stx from disintegrating bacteria and thereby, worsening the complications. Therefore, an effective drug that blocks the Stx production without affecting the growth needs to be urgently developed. In this study, the inhibitory effects of 194 extracts and several compounds originating from a collection of marine sponge-derived actinomycetes were evaluated against the Stx production in EHEC strain EDL933 with the aid of Ridascreen® Verotoxin ELISA assay kit. It was found that treatment with the extracts did not lead to significant reduction in Stx production. However, strepthonium A isolated from the culture of Streptomyces sp. SBT345 (previously cultivated from the Mediterranean sponge Agelas oroides) reduced the Stx production (at 80 μM concentration) in EHEC strain EDL933 without affecting the bacterial growth. The structure of strepthonium A was resolved by spectroscopic analyses including 1D and 2D-NMR, as well as ESI-HRMS and ESI-HRMS2 experiments. This demonstrated the possible application of strepthonium A in restraining EHEC infections.
VI
In the second study, the effect of marine sponge-associated actinomycetes on biofilm formation of staphylococci was assessed. Medical devices such as contact lenses, metallic implants, catheters, pacemakers etc. are ideal ecological niches for formation of bacterial biofilms, which thereby lead to device-related infections. Bacteria in biofilms are multiple fold more tolerant to the host immune responses and conventional antibiotics, and hence are hard-to-treat. Here, the anti-biofilm potential of an organic extract derived from liquid fermentation of Streptomyces sp. SBT343 (previously cultivated from the Mediterranean sponge Petrosia ficiformis) was reported. Results obtained in vitro demonstrated its anti-biofilm (against staphylococci) and non-toxic nature (against mouse macrophage (J774.1), fibroblast (NIH/3T3) and human corneal epithelial cell lines). Interestingly, SBT343 extract could inhibit staphylococcal biofilm formation on polystyrene, glass and contact lens surfaces without affecting the bacterial growth. High Resolution Fourier Transform Mass Spectrometry (HR-MS) analysis indicated the complexity and the chemical diversity of components present in the extract. Preliminary physio-chemical characterization unmasked the heat stable and non-proteinaceous nature of the active component(s) in the extract. Finally, fractionation experiments revealed that the biological activity was due to synergistic effects of multiple components present in the extract.
In the third study, anti-biofilm screening of 50 organic extracts generated from solid and liquid fermentation of 25 different previously characterized sponge-derived actinomycetes was carried out. This led to identification of the anti-biofilm organic extract derived from the solid culture of Streptomyces sp. SBT348 (previously cultivated from the Mediterranean sponge Petrosia ficiformis). Bioassay-guided fractionation was employed to identify the active fraction Fr 7 in the SBT348 crude extract. Further purification with semi-preparative HPLC led to isolation of the bioactive SKC1, SKC2, SKC3, SKC4 and SKC5 sub-fractions. The most active sub-fraction SKC3 was found to be a pure compound having BIC90 and MIC values of 3.95 μg/ml and 31.25 μg/ml against S. epidermidis RP62A. SKC3 had no apparent toxicity in vitro on cell lines and in vivo on the greater wax moth Galleria melonella larvae. SKC3 was stable to heat and enzymatic treatments indicating its non-proteinaceous nature. HR-MS analysis revealed the mass of SKC3 to be 1258.3 Da. Structure elucidation of SKC3 with the aid of 1D and 2D-NMR data is currently under investigation. Further, to obtain insights into the mode of action of SKC3 on S. epidermidis RP62A, RNA sequencing was done. Transcriptome data revealed that SKC3 was recognized by RP62A at 20 min and SKC3 negatively interfered with the central metabolism of staphylococci at 3 h. Taken
VII
together, these findings suggest that SKC3 could be a lead structure for development of new anti-staphylococcal drugs.
Overall, the results obtained from this work underscore the anti-infective attributes of actinomycetes consortia associated with marine sponges, and their applications in natural product drug discovery programs.
Myocardial B-cell infiltration after LAD occlusion in mice is driven by CXCL13
After myocardial infarction, the immune system is activated and regulates wound healing and remodeling processes in the heart.
While the role of T cells has been elucidated already, the function of B cells in myocardial infarction remained relatively unclear until now. It is, however, already known that B cells are of importance in healing processes in other tissues, for example in the skin.
Our studies therefore addressed the role and function of B cells in healing and early remodeling processes in the myocardium after infarction.
Under physiological conditions, only few B cells can be found in the heart. After myocardial infarction, however, which we modelled with a permanent ligation of the left anterior descending artery (LAD) in C57BL/6J mice, we could demonstrate that B lymphocytes accumulate in the early phase after tissue injury (days one to seven) in the myocardium.
To detect B cells, we performed immunofluorescence stainings on cryosections of infarcted hearts using an anti-B220 antibody. Quantitative analysis of tissue infiltration revealed that B cells peaked at day seven. In flow cytometry, we further characterized the B cells infiltrating infarcted tissue. We found that most of them were mature B cells (IgM+, IgD+).
Next, we wanted to outline a potential mechanism responsible for B-cell infiltration to the site of tissue injury. We therefore performed ELISA experiments revealing that CXCL13 was upregulated in scar tissue.
Antibody-mediated neutralization of CXCL13 verifiably attenuated B-cell infiltration.
Treated mice also showed – in the tendency – smaller infarct sizes and an improved survival.
In conclusion, we could show that B lymphocytes infiltrate the myocardium after MI in mice following a local CXCL13 gradient and that it is, most likely, beneficial to inhibit this process.
Improved treatment options for the degenerative joint disease osteoarthritis (OA) are of major interest, since OA is one of the main sources of disability, pain, and socioeconomic burden worldwide [202]. According to epidemiological data, already 27 million people suffer from OA in the US [23]. Moreover, the WHO expects OA to be the fourth most common cause of disability in 2020 [203], illustrating the need for effective and long-lasting therapy options of severe cartilage defects. Despite numerous clinically available products for the treatment of cartilage defects [62], the development of more cartilage-specific materials is still at the beginning.
Hyaluronic acid (HA) is a major component of the cartilaginous extracellular matrix (ECM) and inherently creates a cell-friendly niche by providing cell attachment and migration sites. Furthermore, it is known that the functional groups of HA are well suited for chemical modification. These characteristics render HA an attractive material for hydrogel-based tissue engineering approaches. Poly(glycidol) (PG) as chemical crosslinker basically features similar chemical characteristics as the widely used poly(ethylene glycol) (PEG), but provides additional side groups at each repeating unit that can be further chemically functionalized. With the introduction of PG as multifunctional crosslinker for HA gels, a higher cross-linking density and, accordingly, a greater potential for biomimetic functionalization may be achieved. However, despite the mentioned potential benefits, PG has not been used for cartilage regeneration approaches so far.
The initial aim of the study was to set up and optimize a HA-based hydrogel for the chondrogenic differentiation of mesenchymal stromal cells (MSCs), using different amounts and variations of cross-linkers. Therefore, the hydrogel composition was optimized by the utilization of different PEG diacrylate (PEGDA) concentrations to cross-link thiol-modified HA (Glycosil, HA-SH) via Michael addition. We aimed to generate volumestable scaffolds that simultaneously enable a maximum of ECM deposition. Histological and biochemical analysis showed 0.4% PEGDA as the most suitable concentration for these requirements (Section 5.1.2).
In order to evaluate the impact of a differently designed cross-linker on MSC chondrogenesis, HA-SH was cross-linked with PEGTA (0.6%) and compared to PEGDA (0.4%) in a next step. Following this, acrylated PG (PG-Acr) as multifunctional cross-linker alternative to acrylated PEG was evaluated. It provides around five times more functional groups when utilized in PG-Acr (0.6%) HA-SH hydrogels compared to PEGTA (0.6%) HA-SH hydrogels, thus enabling higher degrees of biomimetic functionalization. Determination of cartilage-specific ECM components showed no substantial differences between both cross-linkers while the deposition of cartilaginous matrix appeared more homogeneous in HA-SH PG-Acr gels. Taken together, we were able to successfully increase the possibilities for biomimetic functionalization in the developed HA-SH hydrogel system by the introduction of PG-Acr as cross-linker without negatively affecting MSC chondrogenesis (Section 5.1.3).
The next part of this thesis focused extensively on the biomimetic functionalization of PG-Acr (0.6%) cross-linked HA-SH hydrogels. Here, either biomimetic peptides or a chondrogenic growth factor were covalently bound into the hydrogels.
Interestingly, the incorporation of a N-cadherin mimetic (HAV), a collagen type II binding (KLER), or a cell adhesion-mediating peptide (RGD) yielded no improvement of MSC chondrogenesis. For instance, the covalent binding of 2.5mM HAV changed morphology of cell nuclei and reduced GAG production while the incorporation of 1.0mM RGD impaired collagen production. These findings may be attributed to the already supportive conditions of the employed HA-based hydrogels for chondrogenic differentiation. Most of the previous studies reporting positive peptide effects on chondrogenesis have been carried out in less supportive PEG hydrogels or in significantly stiffer MeHA-based hydrogels [99, 101, 160]. Thus, the incorporation of peptides may be more important under unfavorable conditions while inert gel systems may be useful for studying single peptide effects (Section 5.2.1).
The chondrogenic factor transforming growth factor beta 1 (TGF-b1) served as an example for growth factor binding to PG-Acr. The utilization of covalently bound TGF-b1 may thereby help overcome the need for repeated administration of TGF-b1 in in vivo applications, which may be an advantage for potential clinical application. Thus, the effect of covalently incorporated TGF-b1 was compared to the effect of the same amount of TGF-b1 without covalent binding (100nM TGF-b1) on MSC chondrogenesis. It was successfully demonstrated that covalent incorporation of TGF-b1 had a significant positive effect in a dose-dependent manner. Chondrogenesis of MSCs in hydrogels with covalently bound TGF-b1 showed enhanced levels of chondrogenesis compared to hydrogels into which TGF-b1 was merely mixed, as shown by stronger staining for GAGs, total collagen, aggrecan and collagen type II. Biochemical evaluation of GAG and collagen amounts, as well as Western blot analysis confirmed the histological results. Furthermore, the positive effect of covalently bound TGF-b1 was shown by increased expression of chondrogenic marker genes COL2A1, ACAN and SOX9. In summary, covalent growth factor incorporation utilizing PG-Acr as cross-linker demonstrated significant positive effects on chondrogenic differentiation of MSCs (Section 5.2.2).
In general, PG-Acr cross-linked HA hydrogels generated by Michael addition represent a versatile hydrogel platform due to their high degree of acrylate functionality. These hydrogels may further offer the opportunity to combine several biological modifications, such as the incorporation of biomimetic peptides together with growth factors, within one cell carrier.
A proof-of-principle experiment demonstrated the suitability of pure PG gels for studying single peptide effects. Here, the hydrogels were generated by the utilization of thiol-ene-click reaction. In this setting, without the supportive background of hyaluronic acid, MSCs showed enhanced chondrogenic differentiation in response to the incorporation of 1.0mM HAV. This was demonstrated by staining for GAGs, the cartilage-specific ECM molecules aggrecan and type II collagen, and by increased GAG and total collagen amounts shown by biochemical analysis. Thus, pure PG gels exhibit the potential to study the effects and interplay of peptides and growth factors in a highly modifiable, bioinert hydrogel environment.
The last section of the thesis was carried out as part of the EU project HydroZONES that aims to develop and generate zonal constructs. The importance of zonal organization has attracted increased attention in the last years [127, 128], however, it is still underrepresented in tissue engineering approaches so far. Thus, the feasibility of zonal distribution of cells in a scaffold combining two differently composed hydrogels was investigated. A HA-SH(FMZ) containing bottom layer was generated and a pure PG top layer was subsequently cast on top of it, utilizing both times thiol-ene-click reaction. Indeed, stable, hierarchical constructs were generated that allowed encapsulated MSCs to differentiate chondrogenically in both zones as shown by staining for GAGs and collagen type II, and by quantification of GAG amount. Thus, the feasibility of differently composed zonal hydrogels utilizing PG as a main component was successfully demonstrated (Section 5.4).
With the first-time utilization and evaluation of PG-Acr as versatile multifunctional cross-linker for the preparation of Michael addition-generated HA-SH hydrogels in the context of cartilage tissue engineering, a highly modifiable HA-based hydrogel system was introduced. It may be used in future studies as an easily applicable and versatile toolbox for the generation of biomimetically functionalized hydrogels for cell-based cartilage regeneration. The introduction of reinforcement structures to enhance mechanical resistance may thereby further increase the potential of this system for clinical applications.
Additionally, it was also demonstrated that thiol-ene clickable hydrogels can be used for the generation of cell-laden, pure PG gels or for the generation of more complex, coherent zonal constructs. Furthermore, thiol-ene clickable PG hydrogels have already been further modified and successfully been used in 3D bioprinting experiments [204]. 3D bioprinting, as part of the evolving biofabrication field [205], offers the possibilities to generate complex and hierarchical structures, and to exactly position defined layers, yet at the same time alters the requirements for the utilized hydrogels [159, 206–209]. Since a robust chondrogenesis of MSCs was demonstrated in the thiol-ene clickable hydrogel systems, they may serve as a basis for the development of hydrogels as so called bioinks which may be utilized in more sophisticated biofabrication processes.
Shiga toxin producing E. coli strains (STEC) are a great concern to human health. Upon an infection with as few as 100 bacteria, humans can develop disease symptoms ranging from watery to bloody diarrhea or even develop the hemolytic uremic syndrome (HUS). The major factor contributing to the disease symptoms is Shiga toxin (Stx) which can bind to the eukaryotic cells in the intestine of the human and induce cell death via apoptosis. Based, among other things, on the microbiota composition, the impact of STEC can vary. Some bacteria of the microbiota can interfere with the colonization of STEC strains in the first place. Others cannot impair the colonization but interfere with the toxin production and there are still others which are even infected by stx encoding phages, being released from STEC strains. Those previously harmless bacteria subsequently contribute to the toxin increase and worsen the disease progression. Since the genetic information of Stx is encoded on a prophage, antibiotic treatment of patients can lead to an increased toxin and stx-phage release and is therefore not recommended. Several STEC epidemics in different countries, which even resulted in the death of some patients, demonstrated that there is an urgent need for alternative treatment strategies.
The E. coli strain Nissle 1917 (EcN) has been used as a probiotic to treat gastrointestinal infections for more than 100 years. It harbors several fitness factors which contribute to the establishment of an intact intestinal barrier in the human gut. Moreover, studies with EcN unraveled that the probiotic E. coli can interfere with the colonization of STEC strains and their toxin production. This study aimed to investigate if EcN could be a possible alternative or supplementary treatment strategy for STEC infected patients, or a preventive treatment for the patient’s close contact persons.
Therefore, EcN was firstly investigated for a possible stx-prophage integration into its’s genome which would eliminate it from being a potential treatment due to the possibility of disease worsening. Despite the presence of the stx-phage surface receptor YaeT, EcN demonstrated a complete resistance towards the lysis and the lysogeny by stx-phages, which was proven by PCR, phage-plaque assays and phage enrichment approaches. Transcriptome data could unravel that a lambdoid prophage in the genome of EcN is involved in the resistance towards the phage infection. Other commensal E. coli tested presented a stx-phage resistance as well and in silico analysis revealed that all of them harbor a complete lambdoid prophage besides the stx-phage susceptible K-12 strain MG1655. We assume that the resistance of EcN towards a stx-phage infection is connected to the presence of an intact lambdoid prophage which interferes with superinfection.
Further experiments regarding the impact of the microcin negative EcN mutant SK22D towards STEC strains depicted that SK22D did not only interfere with the toxin production but also negatively regulated the transcription of the entire stx-prophage in coculture with all STEC strains tested (O157:H7, O26:H11, O145:H25, O103:H2, O111:H- and two O104:H4 isolates from the 2011 outbreak in Germany). This influence on the pathogenic factor production was evinced to be cell contact independent as SK22D could even interfere with the pathogenic factor production when being separated from the STEC strain EDL933 by a Transwell membrane with the pore size of 0.4 µm. From this data we concluded, that factor(s) released by SK22D interfere with the lysis of STEC strains by stabilizing the lysogenic state.
Another positive aspect of EcN towards the pathogenicity of STEC strains was encountered when EcN was incubated with isolated stx-phages. The probiotic strain could reduce the infectivity of the phages towards a MG1655 lysis from ~ 1e7 pfus/ml to 0 after 44 h of incubation. Various approaches to determine the characteristics of the factor(s) of EcN which are involved in the phage inactivation depicted it to be a heat resistant stationary phase protein on the surface of EcN, which could be a component of its biofilm.
Regarding the protective role of EcN we could further evince that SK22D was capable of interfering with the lysogenic K 12 mediated increase of Stx and stx phages. Lysogenic K-12 strains were characterized by a huge increase of Stx and stx-phage production. The presence of SK22D anyhow, could interfere with this K-12 mediated pathogenic factor increase. Transwell and stx phage infection kinetics led to the proposal that SK22D interfered with the stx-phage infection of K-12 strains in the first place rather than disturbing the lysis of lysogenic K 12. The protection from the phage infection could be due to the growth of K 12 strains within the SK22D culture, whereby the phage susceptible strains are masked from phage detection.
Summarizing, this work could underline the beneficial attributes of EcN towards the STEC pathogenicity in vitro. These results should be considered as pioneers for future in vivo studies to enable EcN medication as a supportive STEC infection treatment strategy.
This work summarizes the results of studies on several major aspects of platelet activation and platelet receptor regulation. Therefore, this thesis is divided into four parts.
Platelet activation and aggregation at sites of vascular injury is critical to prevent excessive blood loss, but may also lead to life-threatening ischemic disease states, such as myocardial infarction and stroke. Agonist-induced elevation in cytosolic Ca2+ concentrations is essential for platelet activation in hemostasis and thrombosis. The principal route of Ca2+ influx in platelets is store-operated calcium entry (SOCE). The calcium sensor molecule stromal interaction molecule 1 (STIM1) regulates SOCE by activating the membrane calcium channel protein Orai1, but the exact mechanisms of this interaction are not fully understood. Using affinity chromatography to screen for STIM1 interacting proteins in platelets, bridging integrator 2 (BIN2), an adapter protein belonging to the family of BAR proteins that is mainly expressed in the hematopoietic system, was identified. Newly generated BIN2 KO mice were viable and fertile but their platelets displayed markedly impaired SOCE in response to thapsigargin (TG) as well as agonists acting on immunoreceptor tyrosine-based activation motif (ITAM) or G protein-coupled receptors. This SOCE defect resulted in impaired (hem)ITAM induced platelet activation, aggregate formation under flow and procoagulant activity. As a consequence, mice lacking BIN2 in platelets were protected from occlusive arterial thrombus formation and thrombo-inflammatory cerebral infarct progression in a model of experimental stroke. These results identify BIN2 as a critical regulator of platelet SOCE in thrombosis and thrombo-inflammatory disease.
Integrin αIIbβ3 plays a central role in the adhesion and aggregation of platelets. Integrin activation requires the transmission of a signal from the small cytoplasmic tails of the α or β
subunit to the large extracellular domains resulting in conformational changes of the extracellular domains to enable ligand binding. It was hypothesized that Hic-5 is a novel regulator of integrin αIIbβ3 activation in mice. As demonstrated in the second part of this thesis, lack of Hic-5 had no detectable effect on platelet integrin activation and function in vitro and in vivo under all tested conditions. These results indicate that Hic-5 is dispensable for integrin αIIbβ3 activation and consequently for arterial thrombosis and hemostasis in mice.
The Rho GTPase family members RhoA and Rac1 play major roles in platelet activation at sites of vascular injury. Little is known about possible redundant functions of these Rho GTPases in regulating platelet function. To investigate functional redundancies of RhoA and Rac1 in platelet production and function, mice with MK- and platelet-specific double- deficiencies in RhoA and Rac1 were generated. RhoA/Rac1 double-deficiency phenocopied the respective single knockouts without any additional effects in the double-knockout animals, demonstrating for the first time a functional non-redundancy of RhoA and Rac1 in platelet function.
Antibodies against platelet glycoproteins (GP) trigger platelet destruction in immune thrombocytopenia (ITP) by binding to Fcγ receptors (FcγRs) on immune cells. However, antibodies against the platelet collagen receptor GPVI exert powerful anti-thrombotic action in vivo by inducing ectodomain shedding of the receptor associated with a transient thrombocytopenia. As shown in the final part of this thesis, blockade or deficiency of the inhibitory FcγRIIB abolished sequestration of anti-GPVI opsonized platelets in the hepatic vasculature and GPVI shedding. This process was mediated by liver sinusoidal endothelial cells (LSEC), the major FcγRIIB expressing cell type in the body. Furthermore, LSEC FcγRIIB mediated hepatic platelet sequestration and contributed to thrombocytopenia in mice treated with antibodies against αIIbβ3, the major target antigen in human ITP. These results reveal a novel and unexpected function of hepatic FcγRIIB in the processing of antibody-opsonized platelets.
The brain is the central organ of an animal controlling its behavior. It integrates internal information from the body and external stimuli from the surrounding environment to mediate an appropriate behavioral response. Since the environment is constantly changing, a flexible adjustment of the brain to new conditions is crucial for the animals’ fitness. The ability of the nervous system to adapt to new challenges is defined as plasticity. Over the last few decades great advances have been made in understanding the cellular and molecular mechanisms underlying neuronal plasticity. Plasticity may refer to structural changes physically remodeling the neuronal circuit, or to functional adaptations which are manifested in modified synaptic transmission, and in altered response and firing properties of single neurons. These structural and functional modifications are mediated by a complex interplay of environmental stimuli, intracellular signal transduction cascades, protein modifications, gene translation and transcription, and epigenetic gene regulatory mechanisms. However, especially the molecular mechanisms of environmentally-induced structural neuronal plasticity are still poorly understood.
In this thesis the honey bee was used as an innovative model organism to investigate this issue. The honey bee with its rich behavioral repertoire, highly sophisticated and plastic neuronal system, sequenced genome and full epigenetic machinery is well suited for studying the molecular underpinnings of environmentally-induced neuronal plasticity. Adult honey bees progress through a series of tasks within the dark hive until after about three weeks they start with foraging activities in the external world. The transition from in-hive to outside tasks is associated with remarkable structural neuronal plasticity. Subdivisions of the mushroom body, a brain region related to higher cognitive functions, are increased in volume. The volume expansion is mediated by a remarkable outgrowth of the dendritic network of mushroom body intrinsic neurons, so called Kenyon cells. In parallel, prominent synaptic structures, referred to as microglomeruli, are pruned. Most interestingly for this thesis, the pruning of microglomeruli and the dendritic expansion in Kenyon cells can be induced by a simple light exposure paradigm.
In the first chapter of the present thesis I used this paradigm to induce synaptic plasticity in the mushroom bodies under controlled lab conditions to search for correlating molecular changes which possibly mediate the observed plasticity. I compared the brain transcriptome of light-exposed and dark-kept control bees by whole transcriptome sequencing. This revealed a list of differentially expressed genes (DEGs). The list contains conserved genes which have reported functions in neuronal plasticity, thereby introducing them as candidate genes for plasticity in the honey bee brain. Furthermore, with this transcriptomic approach I discovered many candidate genes with unknown functions or functions so far unrelated to neuronal plasticity suggesting that these novel genes may have yet unrecognized roles in neuronal plasticity. A number of DEGs are known to be methylated or to exert epigenetic modifications on themselves speaking for a strong impact of epigenetic mechanisms in light-induced structural plasticity in the honey bee brain. This notion is supported by a differential methylation pattern of one examined DEG between light-exposed and dark-kept bees as shown in this thesis. Also a plasticity-related microRNA, which is predicted to target genes associated with cytoskeleton formation, was found to be upregulated in light-exposed bees. This speaks for a translation regulatory mechanism in structural plasticity in the honey bee.
Another interesting outcome of this study is the age-dependent expression of DEGs. For some plasticity-related DEGs, the amplitude of light-induced expression differs between one- and seven-day-old bees, and also the basal expression level of many DEGs in naive dark-kept control bees significantly varies between the two age groups. This suggests that the responsiveness of plasticity-related genes to environmental stimuli is also under developmental (age-dependent) control, which may be important for normal maturation and for the regulation of age-related changes in behavior. Indeed, I was able to demonstrate in phototaxis experiments that one- and seven-day-old bees show different behaviors in response to light exposure and thus the correlating age-dependent transcriptional differences may serve as mechanisms promoting age-related changes in behavior.
Together the results of the transcriptomic study demonstrate the successfulness of my approach to identify candidate molecular mechanisms for environmentally-induced structural plasticity in the honey bee brain. Furthermore, the thesis provides seminal evidence for the implication of DNA methylation in this process.
To better understand the role of DNA methylation for neuronal and behavioral plasticity in the honey bee, the second chapter of the thesis aims at characterizing this molecular process under more natural conditions. Therefore, I examined the expression of the DNA methyltransferase 3 (DNMT3) and of Ten-eleven translocation methylcytosine dioxygenase (TET) between in-hive bees and foragers. DNMT3 is responsible for DNA de novo methylation, whereas TET promotes DNA demethylation by converting methylcytosine (5mC) to hydroxymethylcytosine (5hmC). The data suggest that age and experience determine the expression of these two epigenetic key genes. Additionally, in this context, two examined DEGs are shown to be differentially methylated between nurses and foragers. One of these two DEGs, the plasticity related gene bubblegum (bgm), also exhibits an altered DNA methylation pattern in response to light exposure. Hence, these results of my thesis provide additional evidence for the importance of DNA methylation in behavioral and neuronal plasticity.
Results from the second chapter of this thesis also suggest additional functions of DNMT3 and TET to their traditional roles in DNA methylation/demethylation. I show that TET is far more expressed in the honey bee brain than DNMT3. This stands in contrast to the relative scarcity of 5hmC compared to 5mC and points at extra functions of this gene like RNA modifications as reported for Drosophila. Antibody staining against the DNMT3 gene product revealed an unexpected rare localization of the enzyme in the nucleus, but a surprisingly high abundance in the cytoplasm. The role of cytoplasmic DNMT3 is unknown. One possibility for the high abundance in the cytoplasm is a regulatory mechanism for DNA methylation by cytoplasmic-nuclear trafficking, or an additional function of DNMT3 in RNA modification, similar to TET.
Altogether, this thesis points at future research directions for neuronal plasticity by providing promising evidence for the involvement of epigenetic mechanisms and of a number of new candidate genes in environmentally induced structural plasticity in the honey bee brain. Furthermore, I present data suggesting so far unrecognized functions of DNMT3 which certainly need to be experimentally addressed in the future to fully understand the role of this enzyme.
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
(2018)
The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.
The rotation of the earth leads to a cyclic change of night and day. Numerous strategies evolved to cope with diurnal change, as it is generally advantageous to be synchronous to the cyclic change in abiotic conditions. Diurnal rhythms are regulated by the circadian clock, a molecular feedback loop of RNA and protein levels with a period of circa 24 hours. Despite its importance for individuals as well as for species interactions, our knowledge of circadian clocks is mostly confined to few model organisms.
While the structuring of activity is generally adaptive, a rigid temporal organization also has its drawbacks. For example, the specialization to a diurnal pattern limits the breadth of the temporal niche. Organisms that are adapted to a diurnal life style are often poor predators or foragers during night time, constraining the time budget to only diurnal parts of the day/night cycle.
Climate change causes shifts in phenology (seasonal timing) and northward range expansions, and changes in season or in latitude are associated with novel day length – temperature correlations. Thus, seasonal organisms will have some life history stages exposed to novel day lengths, and I hypothesized that the diurnal niche determines whether the day length changes are beneficial or harmful for the organism. I thus studied the effects of day length on life-history traits in a multi-trophic system consisting of the pea aphid Acyrthosiphon pisum and predatory larvae of Chrysoperla carnea (common green lacewing) and Episyrphus balteatus (marmalade hoverfly). In order to identify the mechanisms for phenological constraints I then focused on diurnal rhythms and the circadian clock of the pea aphid.
Aphids reacted to shorter days with a reduced fecundity and shorter reproductive period. Short days did however not impact population growth, because the fitness constraints only became apparent late in the individual’s life. In contrast, E. balteatus grew 13% faster in the shorter day treatment and preyed on significantly more aphids, whereas C. carnea grew 13% faster under longer days and the elevation of predation rates was marginally significant. These results show that day length affects vital life-history traits, but that the direction and effect size depends on species.
I hypothesized that the constraints or fitness benefits are caused by a constricted or expanded time budget, and hence depend on the temporal niche. E. balteatus is indeed night-active and C. carnea appears to be crepuscular, but very little data exists for A. pisum. Hence, I reared the pea aphid on an artificial diet and recorded survival, moulting and honeydew excretion. The activity patterns were clearly rhythmic and molting and honeydew excretion were elevated during day-time. Thus, the diurnal niche could explain the observed, but weak, day length constraints of aphids.
The diurnal niche of some organisms is remarkably flexible, and a flexible diurnal niche may explain why the day length constrains were relatively low in A. pisum. I thus studied its circadian clock, the mechanism that regulates diurnal rhythms. First, I improved an artificial diet for A. pisum, and added the food colorant Brilliant Blue FCF. This food colorant stained gut and honeydew in low concentration without causing mortalities, and thus made honeydew excretion visible under dim red light. I then used the blue diet to raise individual aphids in 16:08 LD and constant darkness (DD), and recorded honeydew excretion and molting under red light every three hours. In addition, we used a novel monitoring setup to track locomotor activity continuously in LD and DD. Both the locomotor rhythm and honeydew excretion of A. pisum appeared to be bimodal, peaking in early morning and in the afternoon in LD. Both metabolic and locomotor rhythm persisted also for some time under constant darkness, indicating that the rhythms are driven by a functional circadian clock. However, the metabolic rhythm damped within three to four days, whereas locomotor rhythmicity persisted with a complex distribution of several free-running periods. These results fit to a damped circadian clock that is driven by multiple oscillator populations, a model that has been proposed to link circadian clocks and photoperiodism, but never empirically tested.
Overall, my studies integrate constraints in phenological adaptation with a mechanistic explanation. I showed that a shorter day length can constrain some species of a trophic network while being beneficial for others, and linked the differences to the diurnal niche of the species. I further demonstrated that a flexible circadian clock may alleviate the constraints, potentially by increasing the plasticity of the diurnal niche.
Involvement of neuronal nitric oxide synthase (NOS-I) PDZ interactions in neuropsychiatric disorders
(2018)
Neuronal nitric oxide (NO) synthase (NOS-I) and its adaptor protein (NOS1AP) have been repeatedly and consistently associated with neuropsychiatric disorders in several genetic association and linkage studies, as well as functional studies. NOS-I has an extended PDZ domain which enables it to interact with postsynaptic density protein 95 (PSD-95) bringing NOS-I in close proximity to NMDA receptors. This interaction allows NMDA receptor activity dependent calcium-influx to activate NOS-I, linking NO synthesis to regulation of glutamatergic signaling pathways. NOS1AP is a PDZ-domain ligand of NOS-I and has been proposed to compete with PSD-95 for NOS-I interaction. Studies performed on post-mortem brain tissues have shown increased expression of NOS1AP in patients with schizophrenia and bipolar disorder, suggesting that increased NOS-I/NOS1AP interactions might be involved in neuropsychiatric disorders possibly through disruption of NOS-I PDZ interactions. Therefore, I have investigated the involvement of NOS-I in different endophenotypes of neuropsychiatric disorders by targeting its specific PDZ interactions in vitro and in vivo. To this end, I used recombinant adeno-associated virus (rAAV) vectors expressing NOS1AP isoforms/domains (NOS1AP-L: full length NOS1AP; NOS1AP-LC20: the last 20 amino acids of NOS1AP-L, containing the PDZ interaction motif suggested to stabilize interaction with NOS-I; NOS1AP-LΔC20: NOS1AP-L lacking the last 20 amino acids; NOS1AP-S: the short isoform of NOS1AP), residues 396-503 of NOS1AP-L (NOS1AP396-503) encoding the full NOS-I interaction domain, and N-terminal 133 amino acids of NOS-I (NOS-I1-133) encoding for the extended PDZ-domain.
Neuropsychiatric disorders involve morphological brain changes including altered dendritic
development and spine plasticity. Hence, I have examined dendritic morphology in primary cultured hippocampal and cortical neurons upon overexpression of constructed rAAV vectors. Sholl analysis revealed that overexpression of NOS1AP-L and NOS1AP-LΔC20 mildly reduced dendritic length/branching. Moreover, overexpression of all NOS1AP isoforms/domains resulted in highly altered spine plasticity including significant reduction in the number of mature spines and increased growth of filopodia. These findings suggest that NOS1AP affects dendritic growth
and development of dendritic spines, which may involve both, increased NOS-I/NOS1AP interaction as well as interaction of NOS1AP with proteins other than NOS-I. Interestingly, the observed alterations in dendritic morphology were reminiscent of those observed in post-mortem brains of patients with neuropsychiatric disorders.
Given the dendritic alterations in vitro, I have examined, whether disruption of NOS-I PDZ interaction would also result in behavioral deficits associated with neuropsychiatric disorders. To this end, rAAV vectors expressing NOS1AP-L, NOS1AP396-503, NOS-I1-133, and mCherry were stereotaxically delivered to the dorsal hippocampus of 6-week-old male C57Bl/6J mice. One week after surgery, mice were randomly separated into two groups. One of those groups underwent three weeks of chronic mild stress (CMS). Afterwards all mice were subjected to a comprehensive behavioral analysis. The findings revealed that overexpression of the constructs did not result in phenotypes related to anxiety or depression, though CMS had an anxiolytic effect independent of the injected construct. Mice overexpressing NOS-I1-133, previously shown to disrupt NOS-I/PSD-95 interaction, showed impaired spatial memory, sensorimotor gating, social interaction, and increased locomotor activity. NOS1AP overexpressing mice showed mild impairments in sensorimotor gating and spatial working memory and severely impaired social interaction. NOS1AP396-503 overexpressing mice also showed impaired social interaction but enhanced sensorimotor gating and reduced locomotor activity. Taken together, these behavioral findings indicate an involvement of NOS-I PDZ interactions in phenotypes associated with positive symptoms and cognitive deficits of psychotic disorders.
In summary, this study revealed an important contribution of NOS-I protein interactions in the development of endophenotypic traits of neuropsychiatric disorders, in particular schizophrenia,
at morphological and behavioral levels. These findings might eventually aid to a better
understanding of NOS-I-dependent psychopathogenesis, and to develop pharmacologically relevant treatment strategies.
The transcription factor MYC is deregulated in over 70% of all human tumors and, in its oncogenic form, plays a major role in the cancer metabolic reprogramming, promoting the uptake of nutrients in order to sustain the biosynthetic needs of cancer cells.
The research presented in this work aimed to understand if MYC itself is regulated by nutrient availability, focusing on the two major fuels of cancer cells: glucose and glutamine.
Initial observations showed that endogenous MYC protein levels strongly depend on the availability of glutamine, but not of glucose. Subsequent analysis highlighted that the mechanism which accounts for the glutamine-mediated regulation of MYC is dependent on the 3´-untranslated region (3´-UTR) of MYC. Enhanced glutamine utilization by tumors has been shown to be directly linked to MYC oncogenic activity and MYC-dependent apoptosis has been observed under glutamine starvation. Such effect has been described in experimental systems which are mainly based on the use of MYC transgenes that do not contain the 3´-UTR. It was observed in the present study that cells are able to survive under glutamine starvation, which leads to cell cycle arrest and not apoptosis, as previously reported. However, enforced expression of a MYC transgene, which lacks the 3´-UTR, strongly increases the percentage of apoptotic cells upon starvation. Evaluation of glutamine-derived metabolites allowed to identify adenosine nucleotides as the specific stimulus responsible for the glutamine-mediated regulation of MYC, in a 3´-UTR-dependent way. Finally, glutamine-dependent MYC-mediated effects on RNA Polymerase II (RNAPII) function were evaluated, since MYC is involved in different steps of global transcriptional regulation. A global loss of RNAPII recruitment at the transcriptional start site results upon glutamine withdrawal. Such effect is overcome by enforced MYC expression under the same condition.
This study shows that the 3´UTR of MYC acts as metabolic sensor and that MYC globally regulates the RNAPII function according to the availability of glutamine. The observations presented in this work underline the importance of considering stress-induced mechanisms impinging on the 3´UTR of MYC.